Clinical trial
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in…
NCT00194480 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00194480 |
|---|---|
| Title | Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users |
| Official title | Treatment of Acute Hepatitis C Virus Infection in Injection Drug Users With Pegylated Interferon for 24 Weeks |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Washington |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Substance-Related Disorders, Hepatitis |
| Intervention type | Drug |
| Interventions | Pegylated Interferon |
| Enrollment | 21 |
| Start date | Apr 1, 2003 |
| Primary completion | Dec 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: